Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by inspecthrgadgeton Apr 22, 2021 8:19am
276 Views
Post# 33043226

Spectral registered a business in Deleware Feb.4/21

Spectral registered a business in Deleware Feb.4/21This together with the amendment of the AGM to a Special Meeting suggests we are getting ready to follow through with an uplist to a real trading platform in the US. We've had Cretendo Communications under contract for 4 months and when I check in on the US symbol EDTFX, it looks near dormant. There is like people say "too much candy" here but the lid is locked down....at least for now. Spectral in my opinion will change the way all other blood filtration plays trade and are subsequently valued. A lot of pressure on this Canadian Ice Breaker however a thorough look at the ship suggests it has the cargo or in case quality science and approvals to cut the expected path. I have three immediate suggestions for required action I'll share in my next muse.

Best,
Gadge
<< Previous
Bullboard Posts
Next >>